The economic burden of common adverse events associated with metastatic colorectal cancer treatment in the United States

Journal of Medical Economics. Jan 2017;20(1):54-62

Adverse events (AEs) associated with treatments for metastatic colorectal cancer (mCRC) may compromise the course of treatment, impact quality-of-life, and increase healthcare resource utilization. This study assessed the direct healthcare costs of common AEs among mCRC patients in the US.